DSM-5 criteria for substance use disorders: recommendations and rationale.
Deborah S Hasin, Charles P O'Brien, Marc Auriacombe...
https://pubmed.ncbi.nlm.nih.gov/23903334/Actively Recruiting
Led by Centre Hospitalier Charles Perrens, Bordeaux · Updated on 2025-11-25
10000
Participants Needed
1
Research Sites
260 weeks
Total Duration
This research aims to understand the long-term experiences of people with substance or behavioral addictions who are receiving care. It is an open, prospective cohort study that assesses participants at the start of their care using standard tools like the Addiction Severity Index ASI and the Mini International Neuropsychiatric Interview MINI. These assessments help capture the medical, neurobiological, sociological, and psychological characteristics of addiction over time. Participants complete self-administered questionnaires at home, which they bring back during follow-up visits that include cognitive testing. Follow-up interviews are scheduled at 3 months, 6 months, and then every 6 months thereafter to monitor changes. The main tool used to evaluate participants is the Addiction Severity Index, which measures addiction severity at the start and throughout the follow-up visits. During the study, participants will be involved in answering questionnaires, cognitive testing, and interviews at regular intervals. Researchers will track the severity of addiction over time to better understand addiction paths. The total duration of participation varies, with ongoing follow-ups every 6 months to capture long-term outcomes and support the studys goals.
CONDITIONS
Understanding the Long-term Paths of People With Addictions
M
Marc AURIACOMBE, Prof, MD, PhD
H
Helen SAVARIEAU
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Hospitalier Charles Perrens, Bordeaux
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants complete self-questionnaires at home and attend visits to take cognitive tests and participate in interviews to assess addiction severity.
Visits at Day 0, Month 3, Month 6, and every 6 months thereafter
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Deborah S Hasin, Charles P O'Brien, Marc Auriacombe...
https://pubmed.ncbi.nlm.nih.gov/23903334/Charles O'Brien
https://pubmed.ncbi.nlm.nih.gov/21477226/Nancy M Petry, Carlos Blanco, Marc Auriacombe...
https://pubmed.ncbi.nlm.nih.gov/23526033/Centre Hospitalier Charles Perrens, Bordeaux
Lead Sponsor